- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04629820
PROductivity Study of Presbyopia Elimination in Rural-dwellers II (PROSPERII)
Effects of Near Vision Spectacle Correction on Work Productivity Among Textile Factory Workers in India
Study Overview
Detailed Description
Globally, 3 billion people do not have the eyeglasses they need to earn, learn, travel safely in traffic and participate in civic life. Among these, 1.1 billion people lack a simple pair of reading glasses to correct impaired near vision, called presbyopia. Presbyopia, the essentially universal decline in unaided near vision that occurs with aging, is the world's most common cause of vision impairment. Loss of accommodation (ability to change focus from distance to near) due to presbyopia can begin as early as age 30 years, commonly becomes functionally apparent by 40, and is essentially complete by 55, meaning that presbyopia is most common at the height of the working years.
Study Plan: This is a randomized trial designed to assess the impact of free spectacles on workplace productivity among Indian textile workers.
Research question: Will providing free glasses to presbyopic Indian textile workers increase work productivity?
Design: Investigator-masked, multi-center randomized controlled trial
Rationale: Although presbyopia is safely, effectively and inexpensively treated with glasses, rates of optical correction in LMICs are as low as 10%. The global productivity loss due to uncorrected presbyopia has been estimated to exceed US$25 billion, and presbyopia is shown to be associated with significant impairment in activities of daily living. Few trials have been published which address the question of whether healthcare interventions can improve work performance as well as workplace retention, especially among persons over the age of 40 in low and middle-income countries (LMICs). The largest reported effect sizes among such trials was the PROSPER trial, which showed that providing inexpensive near vision glasses increased the daily weight of tea picked among presbyopic, mostly-female Indian agricultural workers by more than 5 kg (21.6%) compared to those in the control group. Costs were low, over half of pickers aged >= 40 years met criteria to receive glasses, and wearing compliance reached nearly 90%. There is interest to understand if these results from the agricultural setting can be extended to other financially-important sectors.
Methods : The investigators will enrol 800 textile workers aged 35 years and above with uncorrected presbyopia who are employed by Shahi Exports Private Limited in Karnataka, India. Eligible participants will be randomly assigned to Intervention and Control Groups (1:1). Intervention group participants will receive free reading glasses within a week of undergoing a vision screening at the factory. Control group participants will receive reading glasses at the end of the assessment period (three months after vision screening).
The main outcome 3 month later will be work productivity; secondary outcomes are change in skill grade, change in monthly wage, participants' adherence with spectacle wear, self-assessed self-efficacy score and change of quality of life scores. The intervention cost-effectiveness will be studied.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Smit Gade
- Phone Number: +7023679633
- Email: gade@goodbusiness.com
Study Contact Backup
- Name: Nathan G Congdon, MD, MPH
- Phone Number: 07748751393
- Email: ncongdon1@gmail.com
Study Locations
-
-
Karnataka
-
Bengaluru, Karnataka, India, 560102
- Recruiting
- Good Business Lab
-
Contact:
- Simranjeet Dhir
- Email: simranjeet.d@goodbusinesslab.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 35 years and older
- Have presbyopia, defined as an unaided near visual acuity of N6.3 or worse in both eyes
- Require a new pair of glasses to improve their near vision
- Have a corrected near visual acuity of N4 or better in both eyes
- Have worked in Shahi's production department as tailors or Kajbutton operators for 6 weeks or more
Exclusion Criteria:
- Have ocular pathology in either eye detected during the eye examination, or history of such disease based on self-report
- Have a low likelihood of completing follow-up in the study due to current plans to move out of the area or leave employment at Shahi during the follow-up period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Workers assigned to the intervention group will receive free spectacles of a design they select, based on the worker's measured refractive power and dispensed one week later at the factory by the study ophthalmic personnel.
|
Intervention group workers receive free glasses within one week of undergoing vision assessment (September 2021).
The assessment period will be three months
Other Names:
|
No Intervention: Control
Workers assigned to the Control group will receive similar free glasses at the end of the study assessment (3 months).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference in change in mean efficiency between intervention and control group
Time Frame: Over the three month follow-up period from enrolment to study completion
|
Efficiency is calculated as the proportion of target production realized by a worker per unit time
|
Over the three month follow-up period from enrolment to study completion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Three-month change in skill grade
Time Frame: Between baseline and study end three months later
|
Skill grade ranges from A triple star (highest) to A double star, A star, A, B, and C + (lowest)
|
Between baseline and study end three months later
|
Change in monthly wage
Time Frame: Between baseline and study end three months later
|
Monthly wage (Factory administrative data)
|
Between baseline and study end three months later
|
Adherence with spectacle wear
Time Frame: Between baseline and study end three months later
|
measured weekly by enumerator's unannounced observations of the presence of spectacles worn on the participant's face.
|
Between baseline and study end three months later
|
Group difference in three-month change in self-assessed self-efficacy scores
Time Frame: Between baseline and conclusion of the study three months later
|
Self-assessed self-efficacy scores measured using the Cantril's Ladder, with the best possible score being a 10, and the worst being a 0 (Cantril's Ladder)
|
Between baseline and conclusion of the study three months later
|
Group difference in three-month change of quality of life scores
Time Frame: Between baseline and conclusion of the study three months later
|
Quality of life scores measured using the APEDS Visual Function Questionnaire (VFQ)
|
Between baseline and conclusion of the study three months later
|
Cost effectiveness
Time Frame: Between baseline and study end three months later
|
Full programme costs per individual identified and corrected with presbyopia.
Programme costs include costs incurred in screening test, glasses / replacement and direct/indirect costs for facilitating work-based site.
Benefit will be measured using work productivity.
We will report cost effectiveness distinguishing between study costs and program costs
|
Between baseline and study end three months later
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nathan G Congdon, MD, MPH, Queen's University, Belfast
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MHLS 20_82
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
Lee, Steven, M.D.CompletedMyopia, | Hyperopia, | Astigmatism, | Presbyopia, | Eye Strain,
-
Allotex, Inc.RecruitingPresbyopiaCzechia, Ireland, Turkey, United Kingdom
-
Coopervision, Inc.Centre for Ocular Research & Education, CanadaRecruitingPresbyopiaUnited States, Canada
-
Optall VisionRecruiting
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.LENZ Therapeutics, IncCompleted
-
Allotex, Inc.TerminatedPresbyopiaBelgium, Ireland, United Kingdom
-
Coopervision, Inc.CORECompletedPresbyopiaUnited States, Canada
Clinical Trials on Spectacles
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityUnknown
-
Johns Hopkins UniversityNational Health and Medical Research Council, AustraliaCompletedAstigmatism | Myopia | HyperopiaChina, India
-
Essilor InternationalQueensland University of TechnologyCompleted
-
Avulux, Inc.Completed
-
Shanghai Eye Disease Prevention and Treatment CenterBrien Holden VisionRecruitingBlindness,Visual Impairment, Refractive Error, Cataract, High Myopia, AgingChina
-
Coopervision, Inc.CompletedAmetropiaUnited Kingdom
-
London School of Hygiene and Tropical MedicineBritish Council for Prevention of Blindness; Tanzanian Society for the BlindCompletedUnder- and Uncorrected Significant Refractive ErrorsTanzania
-
Centre for Eye and Vision ResearchThe Hong Kong Polytechnic University; University of WaterlooRecruiting
-
Queen's University, BelfastUniversity of Ulster; University of Zimbabwe; L.V. Prasad Eye Institute; Clearly; New England College of Optometry and other collaboratorsCompletedHyperopia | Long SightZimbabwe